New British Bribery law will mean trouble for American pharmaceutical firms
A new British anti-bribery law taking effect in April, in certain ways more stringent than the Foreign Corrupt Practices Act (“FCPA”) in the United States, is worrying American drug companies enough begin strengthening existing […]
